Connection

Elizabeth Garrett-Mayer to Trastuzumab

Back to Details
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Trastuzumab.
Elizabeth Garrett-Mayer
Connection Strength
0.029
Trastuzumab
  1. A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer Immunol Res. 2014 Oct; 2(10):949-61.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.